India markets open in 2 hours 15 minutes
  • BSE SENSEX

    51,039.31
    +257.62 (+0.51%)
     
  • Nifty 50

    15,097.35
    +115.35 (+0.77%)
     
  • Dow

    31,402.01
    -559.85 (-1.75%)
     
  • Nasdaq

    13,119.43
    -478.54 (-3.52%)
     
  • BTC-INR

    3,468,025.50
    -211,778.25 (-5.76%)
     
  • CMC Crypto 200

    945.15
    -49.52 (-4.98%)
     
  • Hang Seng

    30,074.17
    0.00 (0.00%)
     
  • Nikkei

    29,499.78
    -668.49 (-2.22%)
     
  • EUR/INR

    88.5590
    -0.0978 (-0.11%)
     
  • GBP/INR

    101.9443
    +0.0087 (+0.01%)
     
  • AED/INR

    19.7590
    0.0000 (0.00%)
     
  • INR/JPY

    1.4597
    +0.0024 (+0.16%)
     
  • SGD/INR

    54.8500
    -0.0590 (-0.11%)
     

OBALON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Obalon Therapeutics, Inc. - OBLN

·1-min read

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Obalon Therapeutics, Inc. (NasdaqGS: OBLN) with ReShape Lifesciences Inc. (OTCQB: RSLS) pursuant to which Obalon shareholders will end up owning only approximately 49% of the combined company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-obln/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC
1100 Poydras St., Suite 3200
New Orleans, LA 70163

View source version on businesswire.com: https://www.businesswire.com/news/home/20210122005354/en/

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850